Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ixmyelocel-T in Ischemic Dilated Cardiomyopathy
NCT01670981Phase 2Completed
- Sponsor
- Vericel
- Start
- Feb 2013
- Primary completion
- Feb 2016
- Modality
- Mesenchymal Stem Cells, Hematopoietic Stem Cells
- Countries
- 2
01
Overview
A Phase 2 trial of ixmyelocel-T in ischemic cardiomyopathy (ICM), sponsored by Vericel. Started Feb 2013; status: completed.
02
Drugs
ixmyelocel-T
03
Conditions
ischemic cardiomyopathy (ICM)
Beyond the preview
Go deeper on NCT01670981.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01670981.